Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients-Reference-Cited by-同舟云学术

Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients

Published:2000-07 Issue:6 Volume:11 Page:495-501
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Garufi C,Brienza S,Pugliese P,Aschelter A M,Bensmaine M A,Bertheault-Cvitkovic F,Nisticò C,Giunta S,Caterino M,Giannarelli D,Cosimelli M,Lévi F,Terzoli E

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference22 articles.

1. Oxaliplatin: A review of preclinical and clinical studies

2. Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

3. Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

4. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

5. Chapter 8 Entrainment pathways and the functional organization of the circadian system

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Wide Identification and Characterization of Homeobox Transcription Factors in Phoma sorghina var. saccharum Causing Sugarcane Twisted Leaf Disease;International Journal of Molecular Sciences;2024-05-14

2. Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide;Frontiers in Pharmacology;2022-04-01

3. FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial;Therapeutic Advances in Medical Oncology;2022-01

4. The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day;Drug Design, Development and Therapy;2013-06

5. A Systematic Review of the Use of Quality of Life Measures in Colorectal Cancer Research with Attention to Outcomes in Elderly Patients;Clinical Colorectal Cancer;2007-11